Bexarotene
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00307 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 37 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary cutaneous B-cell lymphoma | KG + DL |
| 2 | Sezary syndrome | KG + DL |
| 3 | lymphosarcoma | KG + DL |
| 4 | lymph node cancer | KG + DL |
| 5 | granulomatous slack skin disease | KG + DL |
| 6 | primary organ-specific lymphoma | KG + DL |
| 7 | folliculotropic mycosis fungoides | KG + DL |
| 8 | localized pagetoid reticulosis | KG + DL |
| 9 | myelodysplastic syndrome | KG + DL |
| 10 | acute lymphoblastic leukemia (disease) | KG + DL |
| 11 | refractory cytopenia of childhood | KG + DL |
| 12 | unclassified myelodysplastic syndrome | KG + DL |
| 13 | acute lymphoblastic/lymphocytic leukemia | KG + DL |
| 14 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 15 | T-cell prolymphocytic leukemia | KG + DL |
| 16 | lymphoma | KG + DL |
| 17 | Crohn’s colitis | KG + DL |
| 18 | lipoid nephrosis | KG + DL |
| 19 | aregenerative anemia | KG + DL |
| 20 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 21 | lymphoma, non-Hodgkin, familial | KG + DL |
| 22 | interdigitating dendritic cell sarcoma | KG + DL |
| 23 | pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma | KG + DL |
| 24 | chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation | KG + DL |
| 25 | psoriasis | KG + DL |
| 26 | indolent primary cutaneous T-cell lymphoma | KG + DL |
| 27 | reticulum cell sarcoma | KG + DL |
| 28 | parapsoriasis | KG + DL |
| 29 | obsolete Hodgkin’s granuloma | KG + DL |
| 30 | mycosis fungoides and variants | KG + DL |
| 31 | subcutaneous panniculitis-like T-cell lymphoma | KG + DL |
| 32 | B-cell neoplasm | KG + DL |
| 33 | immunodeficiency, common variable | KG + DL |
| 34 | colon adenocarcinoma | KG + DL |
| 35 | pityriasis lichenoides | KG + DL |
| 36 | persistent polyclonal B-cell lymphocytosis | KG + DL |
| 37 | acute lichenoid pityriasis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.